Literature DB >> 16118457

Animal models of pulmonary fibrosis.

Mehrnaz Gharaee-Kermani1, Matthew Ullenbruch, Sem H Phan.   

Abstract

In general, there are two types of animal models: natural and experimental. Because there are no natural models for pulmonary fibrosis, an experimental model that reproduces key aspects of the human disease would be useful for the study of this form of lung disease, the natural history of which is not always known. To date, a variety of animal models have been used to investigate mechanisms of pulmonary and other types of fibrosis, including the intratracheal instillation of bleomycin, fluorescein isothiocyanate, or particulate matter, such as silica and asbestos. This chapter will describe two commonly used techniques, namely bleomycin and silica-induced, which have been developed for the study of pulmonary fibrosis in animal models.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16118457     DOI: 10.1385/1-59259-940-0:251

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  18 in total

1.  Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis.

Authors:  Felix Chua; Sarah E Dunsmore; Peter H Clingen; Steven E Mutsaers; Steven D Shapiro; Anthony W Segal; Jürgen Roes; Geoffrey J Laurent
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 2.  Reactive oxygen species as signaling molecules in the development of lung fibrosis.

Authors:  Francisco J Gonzalez-Gonzalez; Navdeep S Chandel; Manu Jain; G R Scott Budinger
Journal:  Transl Res       Date:  2017-10-10       Impact factor: 7.012

3.  Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness.

Authors:  Yael Aschner; Anthony P Khalifah; Natalie Briones; Cory Yamashita; Lior Dolgonos; Scott K Young; Megan N Campbell; David W H Riches; Elizabeth F Redente; William J Janssen; Peter M Henson; Jan Sap; Nathalie Vacaresse; Andras Kapus; Christopher A G McCulloch; Rachel L Zemans; Gregory P Downey
Journal:  Am J Pathol       Date:  2014-03-17       Impact factor: 4.307

4.  β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix.

Authors:  Alysia Kern Lovgren; Jeffrey J Kovacs; Ting Xie; Erin N Potts; Yuejuan Li; W Michael Foster; Jiurong Liang; Eric B Meltzer; Dianhua Jiang; Robert J Lefkowitz; Paul W Noble
Journal:  Sci Transl Med       Date:  2011-03-16       Impact factor: 17.956

5.  WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis.

Authors:  Melanie Königshoff; Monika Kramer; Nisha Balsara; Jochen Wilhelm; Oana Veronica Amarie; Andreas Jahn; Frank Rose; Ludger Fink; Werner Seeger; Liliana Schaefer; Andreas Günther; Oliver Eickelberg
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

6.  Nkx2.5/Csx represses myofibroblast differentiation.

Authors:  Biao Hu; Yue Ming Wu; Zhe Wu; Sem H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-24       Impact factor: 6.914

7.  Laser capture microdissection reveals dose-response of gene expression in situ consequent to asbestos exposure.

Authors:  Qi Yin; Arnold R Brody; Deborah E Sullivan
Journal:  Int J Exp Pathol       Date:  2007-12       Impact factor: 1.925

8.  Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice.

Authors:  Elizabeth M Pierce; Kristin Carpenter; Claudia Jakubzick; Steven L Kunkel; Kevin R Flaherty; Fernando J Martinez; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

9.  Pseudomonas aeruginosa exotoxin pyocyanin causes cystic fibrosis airway pathogenesis.

Authors:  Charles C Caldwell; Yi Chen; Holly S Goetzmann; Yonghua Hao; Michael T Borchers; Daniel J Hassett; Lisa R Young; Dmitri Mavrodi; Linda Thomashow; Gee W Lau
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

10.  2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats.

Authors:  Stevan P Tofovic; Xinchen Zhang; Edwin K Jackson; Hong Zhu; Gordana Petrusevska
Journal:  Vascul Pharmacol       Date:  2009-06-21       Impact factor: 5.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.